Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial (Q44732006)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial |
scientific article |
Statements
1 reference
Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial (English)
1 reference
Mihai Gheorghiade
1 reference
James E Udelson
1 reference
Cesare Orlandi
1 reference
John Ouyang
1 reference
Holly Krasa
1 reference
Christopher A Zimmer
1 reference
Geir Frivold
1 reference
W Herbert Haught
1 reference
Sheiba Meymandi
1 reference
Cezar Macarie
1 reference
Dimitar Raef
1 reference
Patricia Wedge
1 reference
Marvin A Konstam
1 reference
1 November 2008
1 reference
1 reference
52
1 reference
19
1 reference
1540-1545
1 reference
Identifiers
1 reference
1 reference